Riluzole Tablets

Amyotrophic lateral sclerosis (ALS), or motor neuron disease, is a progressive, fatal disease. There are two forms of the disease: limb-onset or bulbar-onset. Both involve loss of upper and lower motor neurons, leading to progressive and irreversible muscle wasting and weakness. Although the pathogenesis of the disease is not fully understood, glutamate toxicity is a possible cause of neuronal damage. Therefore, drugs that modulate glutamate levels in the central nervous system have been investigated as potential treatments.

The main ingredient of this product is riluzole, and its chemical name is: 2-chloro-6-trifluoromethoxybenzothiazole.

This product is white or off-white thin flakes.

For the treatment of patients with amyotrophic lateral sclerosis, it can prolong survival and/or delay the need for tracheotomy.

The recommended dose is 1 tablet twice a day. Take orally at a fixed time each day, such as 1 tablet in the morning and 1 tablet in the evening. If you miss a dose, take the next tablet as planned.

Common adverse reactions to this product are fatigue, stomach discomfort, and increased plasma transaminase levels. Other adverse reactions are less common. Neutropenia is occasionally seen. This product may cause other adverse reactions not listed here. If you experience any changes in your health while taking this product, please inform your doctor or pharmacist.

Those who are allergic to this product and its main ingredients. Those with abnormal liver function or abnormally elevated transaminase levels. Those who are pregnant or breastfeeding.

Precautions for children: There is no research data on the use of this product by children. Precautions for pregnancy and lactation: Pregnant and lactating women are prohibited. Precautions for the elderly: The medication for elderly patients is the same as that for healthy adults.

Drug interactions may occur if used with other drugs. Please consult your pharmacist or doctor for details.

Sealed and stored in a cool place.

50 mg

24 months